Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

Trochanteric Bursitis Clinical Trial

Official title:
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the safety and efficacy of FX006 in bursal injections and to assess the patient's impression to change in their chronic pain, following treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04182672
Study type	Interventional
Source	The University of Texas Health Science Center, Houston
Contact
Status	Completed
Phase	Phase 2
Start date	August 12, 2020
Completion date	December 14, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05662579` - Core Resistance and Lateral Hip Pain	N/A
Recruiting	`NCT05516563` - LEAP-Ireland Feasibility Trial of Exercise and Education for Gluteal Tendinopathy	N/A
Recruiting	`NCT06297148` - The HIP Self-management Study	N/A
Completed	`NCT04420572` - Comparison of Ozone and Steroid Injection in Patients With Greater Trochanteric Pain Syndrome	N/A
Withdrawn	`NCT04299802` - Percutaneous Ultrasonic Tenotomy Versus Platelet Rich Plasma for Gluteal Tendinopathy	N/A
Recruiting	`NCT05872971` - Dry Needling and Lateral Hip Pain (GTPS)	N/A